TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2018. The put-call ratio across all filers is 5.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,000 | – | 1,302 | +2356.6% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 53 | -84.5% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 342 | +71.0% | 0.00% | – |
| Q4 2017 | $1,000 | -97.0% | 200 | -95.8% | 0.00% | – |
| Q3 2017 | $33,000 | +1550.0% | 4,807 | +1289.3% | 0.00% | – |
| Q2 2017 | $2,000 | -85.7% | 346 | -76.8% | 0.00% | – |
| Q1 2017 | $14,000 | +27.3% | 1,494 | -45.7% | 0.00% | – |
| Q4 2016 | $11,000 | +1000.0% | 2,751 | +1577.4% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 164 | +51.9% | 0.00% | – |
| Q3 2015 | $1,000 | -98.3% | 108 | -91.2% | 0.00% | – |
| Q2 2015 | $58,000 | +2800.0% | 1,227 | +513.5% | 0.00% | – |
| Q1 2014 | $2,000 | -33.3% | 200 | -13.4% | 0.00% | – |
| Q3 2013 | $3,000 | – | 231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 664,000 | $2,543,000 | 0.82% |
| GREAT POINT PARTNERS LLC | 452,375 | $1,733,000 | 0.44% |
| Clearline Capital LP | 267,915 | $1,026,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,149,000,000 | 0.18% |
| Rock Springs Capital Management LP | 662,500 | $2,537,000 | 0.16% |
| Eventide Asset Management | 600,000 | $2,298,000 | 0.14% |
| Granahan Investment Management | 657,496 | $2,518,000 | 0.08% |
| Candriam S.C.A. | 374,000 | $1,432,000 | 0.03% |
| Tekla Capital Management LLC | 192,322 | $737,000 | 0.03% |
| DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.02% |